Categories: ASEAN News

Biotech firm in Singapore hoping to release new covid-19 treatment by 2021

SINGAPORE — Another Covid-19 treatment by homegrown biotech company Humming bird Bioscience aims and joins significant names in making steps to battle COVID-19, could open up in Singapore beyond by early 2021

Company co-founder said the experimental antibody therapy works by “building a wall around” contaminated cells, points to supply necessary treatment even as big pharmaceutical company make progress in the development of vaccine. 

“The key to tackling this global pandemic is building an arsenal of options, both preventative like vaccines, and treatments … like antibody therapies,” Jerome Boyd-Kirkup said.

News comes as trusts for making sure a COVID-19 vaccine got a boost Monday, Moderna U.S. based pharmaceutical said its test antibody had demonstrated 94.5% effective in preventing COVID-19. Followed by Pfizer U.S. drugmaker and BioNTech German partner said their vaccine is more than 90% effective.

After company received an approval from the Health authorities a small-scale human trials of Hummingbird 115 began in Singapore last month. They are expecting a progress to a larger tests, as phase three trials beyond by December in Singapore, as the company aims for a new year batch of the treatment.

“We’re aiming for early 2021 for widespread accessibility of this therapy to patients,” said Boyd-Kirkup.

In any case, he included it’s “a small early to speculate” what the treatment’s pricing models may be.

When it was launched in Singapore in the year 2015, Hummingbird Bioscience for all intents and purposes pharmaceutical has received $65 million from investors including South Korea’s SK Holdings and Mirae Asset Capital to support its sites across Asia, Europe and the U.S, which literally is quite significant. Boyd-Kirkup basically said the company mostly is not bound by any distribution agreements, and is instead working with partners and regulators internationally to kind of deliver treatments “where they’re needed in a particularly big way.

Katherine S

1/4 German, 3/4 Malaysian. I write, follow and monitor closely political news happening in Malaysia, and other happening news in the ASEAN region. Newswriter for the best ASEAN news website - The Asian Affairs.

Recent Posts

Johor-Singapore Special Economic Zone (SEZ) attracts new “queen bee” technology investors.

Johor-Singapore Special Economic Zone (JS-SEZ) is fast developing into an excellent destination of high-impact commitments to industries. Later in early…

January 29, 2026

Hpa-an and Pindaya Win 2026 ASEAN Clean Tourist City Awards

Myanmar's Hpa-an and Pindaya have clinched the prestigious ASEAN Clean Tourist City Awards for 2026, recognizing exemplary cleanliness, sustainability, and…

January 29, 2026

Vietnam Becomes World’s 3rd Largest Cassava Exporter, Shipping $1.3 Billion in Crops

Vietnam solidified its status as the world's third-largest cassava exporter in 2026, shipping crops worth approximately $1.3 billion—behind only Thailand…

January 29, 2026

MAS Keeps Singapore Dollar Policy Unchanged; Raises 2026 Inflation Forecasts

The Monetary Authority of Singapore (MAS) maintained its Singapore Dollar policy unchanged at its January 29, 2026 review, keeping the…

January 29, 2026

Elon Musk Announces the Retirement of Model S and Model X Production to Prioritize Humanoid Robotics

Elon Musk declared during Tesla's Q4 2025 earnings call on January 28, 2026, that Model S and Model X production…

January 29, 2026

New Trailer and Cast Revealed for Bridgerton Season 4; Upcoming K-Dramas for February 2026 Listed

Bridgerton Season 4 trailer dropped Christmas Day, unveiling Benedict Bridgerton's romance with Sophie Baek (Yerin Ha) at a masquerade ball,…

January 29, 2026

This website uses cookies.

Read More